StonvexLoading…
StonvexCore line items from EXLS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-27 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $585.50M | $570.35M | $2.09B | $1.55B | $1.02B |
Operating Income | Not available | $91.83M | $313.75M | $235.73M | $159.55M |
Net Income | Not available | $67.08M | $251.02M | $190.77M | $132.61M |
EPS (Diluted) | $0.56 | $0.43 | $1.54 | $1.17 | $0.81 |
Total Assets | Not available | $1.68B | $1.70B | $1.73B | $1.71B |
Total Liabilities | Not available | $897.58M | $789.53M | $781.24M | $647.55M |
Cash & Equivalents | Not available | $145.41M | $146.33M | $160.31M | $149.13M |
Free Cash Flow OCF − CapEx | Not available | $-11.21M | $298.12M | $191.61M | $85.25M |
Shares Outstanding | Not available | 153.00M | 156.43M | 158.88M | 161.83M |